Bliv Review
Best for: mainstream telehealth GLP-1 access
Telehealth provider focused on personalized GLP-1 weight loss programs.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Bliv is one of the most affordable GLP-1 options on the market.
Bliv at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $58/mo
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Bliv
Each dimension is scored algorithmically from Bliv’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.7/10At $58/mo, Bliv runs about 66% below the $170 median for GLP-1 providers.
Effectiveness25%
7.7/10Bliv offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.5/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
5.7/10Bliv's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.5/10Bliv provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Bliv review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Bliv offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Bliv's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Bliv: a bargain-priced GLP-1 program that keeps its cards close
Bliv (the brand behind joinbliv.com) is one of the most aggressively priced compounded GLP-1 sellers we track, leading with compounded semaglutide at $58 a month. That number alone will put it near the top of a lot of price-sorted shopping lists, and for cost-first shoppers that is the whole pitch. But Bliv is also one of the more tight-lipped providers in this space: it publishes a price and a short list of perks, then leaves most of the program mechanics undescribed. This review is about squaring those two things — a genuinely low headline rate against a thin paper trail — so you know what you are actually buying.
How the pricing really works
Bliv frames its rate as 'as low as $58 per month' for compounded semaglutide, and that phrasing matters. 'As low as' usually signals an introductory or lowest-dose figure rather than a flat rate you pay forever, so treat $58 as the entry point, not a guaranteed lifetime price. Tirzepatide — the dual-action molecule in Mounjaro and Zepbound — starts at a modestly higher monthly figure, still under a hundred dollars. For context, our category median sits at $170 a month, so even Bliv's tirzepatide line comes in well below what a typical competitor charges, and its semaglutide rate is a fraction of it.
The medication price is the product price here — Bliv sells the drug itself rather than burying it inside a separate membership tier. Free shipping is included, and the company advertises 'no contracts,' meaning you are not locked into a multi-month commitment up front. What is genuinely unclear is whether a provider consult is baked into that monthly figure or billed separately. Bliv does not spell that out, so before you sign up, confirm whether the visit with the prescriber is part of the price or an add-on.
The medications and how they're dispensed
Bliv offers compounded semaglutide and compounded tirzepatide — the same two active ingredients in the brand-name injectables, made by a compounding pharmacy rather than the original manufacturer. Compounded versions exist because they can be sold far cheaper, which is exactly how Bliv hits these prices. The trade-off is that compounded drugs are not FDA-approved products; they are permitted under specific pharmacy rules, and quality rides entirely on the pharmacy doing the work.
That is where Bliv is frustratingly quiet. It does not name the compounding pharmacy that fills its prescriptions, nor does it publish accreditation details (such as a 503A or 503B designation or board status). We have no pharmacy partner on file for Bliv. That doesn't mean the supply is bad — plenty of legitimate sellers use reputable 503-class pharmacies — but it does mean you can't verify the source yourself, and verification is the single most important thing with compounded GLP-1s.
What sets Bliv apart — and what it leaves out
The honest differentiator is price plus simplicity. Bliv strips the offer down to a low number, free shipping, no contract, and phone support. There is no sprawling membership ladder, no bundled coaching upsell visible, no confusing à-la-carte menu. For someone who just wants the medication at the lowest defensible price and a human to call, that minimalism is the appeal.
Phone support deserves a specific callout because many budget telehealth brands route everything through chat or email. A published phone line is a small but real trust signal — it means there is someone to reach if a shipment is late or a dose question comes up.
The flip side is how much Bliv doesn't tell you. The state-availability map isn't disclosed on the site — the company directs you to email support to find out whether it serves your state. That is a meaningful gap, because GLP-1 telehealth is regulated state by state, and you can't confirm Bliv even operates where you live without contacting them first.
- Where you get clarity: price for both drugs, free shipping, no contract, phone support.
- Where you don't: the compounding pharmacy and its accreditation, whether a consult fee is separate, which states are served, and the details of medical oversight.
Who should choose Bliv — and who should skip it
Bliv makes sense if you are paying cash, the price is your top filter, and you are comfortable doing a little homework — emailing support to confirm your state, asking which pharmacy fills the order, and clarifying whether the consult is included. If you've used compounded GLP-1s before and know what questions to ask, the savings here are real.
Skip it if you want everything documented before you hand over a card. Shoppers who need to see the pharmacy's accreditation, a published state list, and a clear breakdown of what the visit costs will find Bliv's silence uncomfortable — and reasonably so. Anyone who specifically wants brand-name Wegovy, Ozempic, or Zepbound should also look elsewhere, since Bliv is a compounded-only offering.
Trust, safety, and medical oversight
To Bliv's credit, we found no FDA warning letters or enforcement actions on file against it, which is a clean baseline. But a clean record is not the same as strong, visible oversight. Our confidence here is limited by how little Bliv discloses: no named pharmacy, no accreditation, no public detail on how prescribing is supervised. We were able to live-verify the prices and the perks directly from joinbliv.com, but the program's clinical guts remain a black box. You can read more about how we weigh these signals in our scoring methodology.
Bottom line
Bliv is a price-led, no-frills way into compounded semaglutide and tirzepatide, and at $58 a month it undercuts most of the field by a wide margin against our $170 median. The catch is information: undisclosed states, an unnamed pharmacy, and unclear consult terms mean you have to chase down the basics yourself before trusting it. If you'll make that one phone call or email, Bliv can be a legitimately cheap option. If you want the answers handed to you up front, a more transparent provider is worth the extra cost.
For a side-by-side, Telos Rx ($49/month) and bmiMD ($99/month) are the most comparable options to weigh against Bliv.
Ready to start with Bliv?
Starting at $58/month. See current pricing and start your free consultation.
Alternatives to Bliv
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Bliv review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Bliv?
Starting at $58/month. See current pricing and start your free consultation.